"Unsere klinischen und wissenschaftlichen Schwerpunkte liegen auf den Gebieten Schlaganfall, neurodegenerative Erkrankungen wie der Parkinson Krankheit oder Hirnleistungsstörungen, auf neuroimmunologischen und auf neuromuskulären Erkrankungen. In diesen Bereichen haben wir auch verschiedene Spezialambulanzen eingerichtet. Patienten mit einem Schlaganfall behandeln wir auf einer spezialisierten Schlaganfallintensivstation, der sogenannten Stroke Unit. Die enge Zusammenarbeit mit der Klinik für Neuroradiologie und der Klinik für Neurochirurgie ermöglicht uns eine rasche Akutversorgung von Schlaganfallpatienten auf höchstem internationalen Standard."

During the past decade, Department of Neurology, Saarland University conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Department of Neurology, Saarland University" are "Acetylcholine" (1 trials), "Parkinson Disease" (1 trials), "Parkinson´s Disease" (1 trials) and "SPECT" (1 trials). Many other conditions were trialed in "Department of Neurology, Saarland University" in a lesser frequency.

The vast majority of trials in "Department of Neurology, Saarland University" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Department of Neurology, Saarland University". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Department of Neurology, Saarland University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Neurology, Saarland University, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".